Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Edaravone Effect on Outcomes in Acute Ischemic Stroke
IRCT20210602051472N1Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of edaravone in ischemic stroke, sponsored by Hamadan University of Medical Sciences. Started Jul 2021; status: completed.
02
Drugs
edaravone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20210602051472N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210602051472N1.